Tariffs & Workforce Talent: Two Factors Shaping Healthcare M&A in 2025
v
In a recent interview with Healthcare Brew, Bryan Hughes, Managing Director of PMCF Investment Banking, cited PMCF’s Q2 2025 Medical Technology Pulse, which found there were 104 MedTech transactions in Q2 2025, compared to 128 in Q2 2024.
“What we’ve seen is it’s really paused a lot of discussions around potential M&A activity, as well as other investments,” Hughes said.
Hughes, who leads PMCF’s healthcare team, said firms are still navigating transactions despite uncertainty. Still, PPE products like gloves, masks, and gauze, which are mostly imported, could be affected by potential tariffs.
There’s “much less room to absorb some of that cost pressure” for PPE, Hughes said.
Workforce Stability
Concurrently, in the healthcare sector, home-based care transactions are witnessing a shift in buyer focus on workforce stability. Mike Brooks, PMCF Vice President, highlighted in an interview with Home Health Care News that buyers are now seeking companies with low turnover and a scalable workforce pipeline to manage immediate labor gaps while achieving economies of scale.
“Specific areas of increased M&A activity include non-medical care due to its ability to scale with lower clinical staffing requirements, and cross-subsector deals between home health and non-medical, allowing acquirers to diversify across services or leverage technology-enabled models to increase existing staff utilization,” Brooks said.
To read the Healthcare Brew article, click here
To read the Home Health Care News article (subscription required) , click here
To learn more about PMCF’s Healthcare and MedTech practice, click here
More Articles
Distributors See Improving M&A Opportunity In 2026
After a year defined by uneven activity and macro uncertainty, M&A momentum enters 2026 with improving financing conditions, renewed buyer confidence, and substantial capital on the sidelines, creating a more constructive environment for well-positioned middle-market distributors.
HCM M&A Outlook 2026: AI, Specialization, and Global Shifts Shape Deal Flow
After years of volatility and transformation, the Human Capital Management (HCM) industry now finds itself navigating a landscape where geopolitical tensions and technological acceleration collide to create both unique challenges and new frontiers for growth.
Continued Momentum Drives Optimistic 2026 Plastics M&A Outlook
From transaction volume to EBITDA multiples, key indicators for plastics M&A are trending upward as 2026 begins, according to PMCF Investment Banking Managing Director John Hart.
The Long-Term Perspective: Insights from PMCF’s 30 Years in Middle-Market M&A
Thirty years ago, PMCF Investment Banking set out with a clear mission: to redefine how middle‑market businesses approach M&A.
2026 Medtech M&A Outlook Strengthens as Buyers Prioritize Innovation and Resilience
Medtech is entering 2026 with a healthier M&A environment supported by improved financing conditions, resilient sector performance, and a more straightforward path for strategic buyers and private equity.